Novel Anti-nectin-4 antibodies, conjugated biological molecules, pharmaceutical compositions and uses thereof

TW202626659APending Publication Date: 2026-07-01OBI PHARMA INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: TW114133095
Authority / Receiving Office: TW · TW
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2024-11-27
Filing Date: 2025-08-29
Publication Date: 2026-07-01

Application Information

Patent Timeline

27 Nov 2024

Priority

29 Aug 2025

Application

TW114133095

01 Jul 2026

Publication

TW202626659A

IPC: C07D491/22; A61K9/08; A61K47/02; A61K47/12; A61K47/18; A61K47/26; A61K47/36; A61K47/68; A61P35/00; C07K16/28

Inventors: 賴明添; 黃鐙毅

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention provides an antibody or an antigen-binding portion thereof that binds to Nectin-4. Also provided is an antibody-drug conjugate (ADC) including a drug moiety conjugated to the anti-Nectin-4 antibody or antigen-binding portion thereof. Also disclosed are methods of using the antibody or ADC for inhibiting cancer cell proliferation.

Need to check novelty before this filing date? Find Prior Art